Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$8.15 - $13.9 $1.29 Million - $2.2 Million
-157,968 Closed
0 $0
Q4 2020

Feb 08, 2021

SELL
$14.94 - $18.3 $1.61 Million - $1.98 Million
-107,955 Reduced 40.6%
157,968 $2.88 Million
Q3 2020

Nov 13, 2020

BUY
$15.45 - $18.12 $4.11 Million - $4.82 Million
265,923 New
265,923 $4.15 Million

Others Institutions Holding FRLN

# of Institutions
1
Shares Held
30.1K
Call Options Held
0
Put Options Held
0

About Freeline Therapeutics Holdings plc


  • Ticker FRLN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,972,300
  • Description
  • Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. Its advanced product candidate is verbrinacogene setparvovec (FLT180a), a gene therapy product candidate that is in P...
More about FRLN
Track This Portfolio

Track Fil LTD Portfolio

Follow Fil LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.